Content » Vol 71, Issue 6

Peptide T a new treatment for psoriasis? A study of nine patients.

Marcusson JA, Talme T, Wetterberg L, Johansson O
DOI: 10.2340/0001555571479483


Nine patients with recalcitrant and long-standing psoriasis were treated over a period of 28 days with 2 mg Peptide T iv, once daily (22-34 micrograms/kg bodyweight). Eight of them showed an improvement of less than 50% by day 28 and one deteriorated. The patients were evaluated for a further 3 months when no topical or systemic treatment was given. Five patients recovered by more than 50%, during the months following termination of the therapy. Two patterns of healing were noted: firstly, a steady clearance beginning immediately with the Peptide T infusions; secondly, a clearance pattern preceded by deterioration. No serious side effects were noted.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.